调整纳米容器的核壳尺寸以调节其对阿霉素的装载和释放性能。
Tuning core vs. shell dimensions to adjust the performance of nanoscopic containers for the loading and release of doxorubicin.
机构信息
Departments of Chemistry and Chemical Engineering, Texas A&M University, College Station, TX 77842-3012, USA.
出版信息
J Control Release. 2011 May 30;152(1):37-48. doi: 10.1016/j.jconrel.2011.01.009. Epub 2011 Jan 15.
Detailed studies were performed to probe the effects of the core and shell dimensions of amphiphilic, shell crosslinked, knedel-like polymer nanoparticles (SCKs) on the loading and release of doxorubicin (DOX), a widely-used chemotherapy agent, in aqueous buffer, as a function of the solution pH. Effects of the nanoparticle composition were held constant, by employing SCKs constructed from a single type of amphiphilic diblock copolymer, poly(acrylic acid)-b-polystyrene (PAA-b-PS). A series of four SCK nanoparticle samples, ranging in number-average hydrodynamic diameter from 14-30 nm, was prepared from four block copolymers having different relative block lengths and absolute degrees of polymerization. The ratios of acrylic acid to styrene block lengths ranged from 0.65 to 3.0, giving SCKs with ratios of shell to core volumes ranging from 0.44 to 2.1. Although the shell thicknesses were calculated to be similar (1.5-3.1 nm by transmission electron microscopy (TEM) calculations and 3.5-4.9 nm by small angle neutron scattering (SANS) analyses), two of the SCK nanoparticles had relatively large core diameters (19±2 and 20±2 nm by TEM; 17.4 and 15.3 nm by SANS), while two had similar, smaller core diameters (11±2 and 13±2 nm by TEM; 9.0 and 8.9 nm by SANS). The SCKs were capable of being loaded with 1500-9700 DOX molecules per each particle, with larger numbers of DOX molecules packaged within the larger core SCKs. Their shell-to-core volume ratio showed impact on the rates and extents of release of DOX, with the volume occupied by the poly(acrylic acid) shell relative to the volume occupied by the polystyrene core correlating inversely with the diffusion-based release of DOX. Given that the same amount of polymer was used to construct each SCK sample, SCKs having smaller cores and higher acrylic acid vs. styrene volume ratios were present at higher concentrations than were the larger core SCKs, and gave lower final extents of release., Higher final extents of release and faster rates of release were observed for all DOX-loaded particle samples at pH 5.0 vs. pH 7.4, respectively, ca. 60% vs. 40% at 60 h, suggesting promise for enhanced delivery within tumors and cells. By fitting the data to the Higuchi model, quantitative determination of the kinetics of release was made, giving rate constants ranging from 0.0431 to 0.0540 h⁻¹/² at pH 7.4 and 0.106 to 0.136 h⁻¹/² at pH 5.0. In comparison, the non-crosslinked polymer micelle analogs exhibited rate constants for release of DOX of 0.245 and 0.278 h⁻¹/² at pH 7.4 and 5.0, respectively. These studies point to future directions to craft sophisticated devices for controlled drug release.
详细研究了两亲性、壳交联、纽结状聚合物纳米粒子(SCKs)的核和壳尺寸对阿霉素(DOX)加载和释放的影响,DOX 是一种广泛使用的化疗药物,在水性缓冲液中作为溶液 pH 的函数。通过使用由单一类型两亲性嵌段共聚物聚(丙烯酸)-b-聚苯乙烯(PAA-b-PS)构建的 SCK,保持纳米粒子组成的恒定。制备了一系列四种 SCK 纳米粒子样品,数均水动力直径从 14-30nm 不等,由四种具有不同相对嵌段长度和绝对聚合度的嵌段共聚物制备。丙烯酸与苯乙烯嵌段长度的比例从 0.65 到 3.0,壳核体积比从 0.44 到 2.1。尽管通过透射电子显微镜(TEM)计算得出的壳厚度被计算为相似(1.5-3.1nm TEM 计算和 3.5-4.9nm 通过小角中子散射(SANS)分析),但两种 SCK 纳米粒子具有相对较大的核心直径(19±2nm 和 20±2nm 通过 TEM;17.4nm 和 15.3nm 通过 SANS),而两种具有相似的较小核心直径(11±2nm 和 13±2nm 通过 TEM;9.0nm 和 8.9nm 通过 SANS)。SCKs 能够每粒装载 1500-9700 个 DOX 分子,较大数量的 DOX 分子封装在较大核心 SCK 内。它们的壳核体积比影响 DOX 的释放速率和程度,与聚苯乙烯核相比,聚(丙烯酸)壳的体积与 DOX 的扩散释放呈反比。鉴于每种 SCK 样品都使用相同量的聚合物构建,具有较小核心和较高丙烯酸与苯乙烯体积比的 SCK 浓度高于较大核心 SCK,并且最终释放程度较低。在 pH5.0 时,所有载 DOX 的粒子样品的最终释放程度更高,释放速度更快,分别为 60h 时的 60%和 40%,这表明在肿瘤和细胞内增强递送的潜力。通过将数据拟合到 Higuchi 模型,对释放动力学进行了定量测定,在 pH7.4 时的速率常数范围为 0.0431 至 0.0540h-1/2,在 pH5.0 时为 0.106 至 0.136h-1/2。相比之下,非交联聚合物胶束类似物在 pH7.4 和 5.0 时释放 DOX 的速率常数分别为 0.245 和 0.278h-1/2。这些研究为设计用于控制药物释放的复杂设备指明了未来的方向。